Number of items: 14.
2023
Greenland, K. K., Pennel, K., Cioccoloni, G., Rogerson, C., Barnieh, F. M. and Speirs, V.
(2023)
Trailblazers in cancer research: the next generation – the British Association of Cancer Research early-career conference.
Biology Open, 12(10),
bio060121.
(doi: 10.1242/bio.060121)
(PMID:37846765)
(PMCID:PMC10602000)
Beach, C. et al.
(2023)
Innate immune receptor C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy in tumours with immunosuppressive microenvironments.
Journal of Clinical Investigation,
(Accepted for Publication)
Vande Voorde, J. et al.
(2023)
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target.
Nature Metabolism, 5(8),
pp. 1303-1318.
(doi: 10.1038/s42255-023-00857-0)
(PMID:37580540)
Hatthakarnkul, P. et al.
(2023)
Protein expression of S100A2 reveals it association with patient prognosis and immune infiltration profile in colorectal cancer.
Journal of Cancer, 14(10),
pp. 1837-1847.
(doi: 10.7150/jca.83910)
(PMID:37476187)
(PMCID:PMC10355195)
Pennel, K., Morrow, E., Hatthakarnkul, P. , Leslie, H. , Mallon, E., Andersen, D., Jamieson, N. , McMillan, D. , Roseweir, A. and Edwards, J.
(2023)
High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.
Cancer Medicine, 12(12),
pp. 13225-13240.
(doi: 10.1002/cam4.6014)
(PMID:37199043)
(PMCID:PMC10315752)
Wood, C. S. et al.
(2023)
Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases.
Cancer Research, 83(8),
pp. 1329-1344.
(doi: 10.1158/0008-5472.CAN-22-2794)
(PMID:37057593)
(PMCID:PMC10102851)
Alexander, P.G., van Wyk, H.C. , Pennel, K.A.F., Hay, J., McMillan, D.C. , Horgan, P.G. , Roxburgh, C.S.D. , Edwards, J. and Park, J.H.
(2023)
The Glasgow Microenvironment Score and risk and site of recurrence in TNM I–III colorectal cancer.
British Journal of Cancer, 128(4),
pp. 556-567.
(doi: 10.1038/s41416-022-02069-x)
(PMID:36476660)
(PMCID:PMC9938140)
2022
Pennel, K. A. F. et al.
(2022)
CXCL8 expression is associated with advanced stage, right sidedness, and distinct histological features of colorectal cancer.
Journal of Pathology: Clinical Research, 8(6),
pp. 509-520.
(doi: 10.1002/cjp2.290)
(PMID:35879507)
(PMCID:PMC9535100)
Alexander, P. G. et al.
(2022)
The relationship between the Glasgow Microenvironment Score and markers of epithelial-mesenchymal transition in TNM II-III colorectal cancer.
Human Pathology, 127,
pp. 1-11.
(doi: 10.1016/j.humpath.2022.05.012)
(PMID:35623467)
Patel, M. et al.
(2022)
Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer.
British Journal of Cancer, 126(12),
pp. 1704-1714.
(doi: 10.1038/s41416-022-01729-2)
(PMID:35173303)
(PMCID:PMC9174220)
2021
Knight, J. R.P. et al.
(2021)
MNK inhibition sensitizes KRAS-mutant colorectal cancer to mTORC1 inhibition by reducing eIF4E phosphorylation and c-MYC expression.
Cancer Discovery, 11(5),
pp. 1228-1247.
(doi: 10.1158/2159-8290.CD-20-0652)
(PMID:33328217)
Al-Badran, S. S.F. et al.
(2021)
Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.
Journal of Pathology: Clinical Research, 7(2),
pp. 121-134.
(doi: 10.1002/cjp2.193)
(PMID:33338327)
Alexander, P.G. et al.
(2021)
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
British Journal of Cancer, 124,
pp. 786-796.
(doi: 10.1038/s41416-020-01168-x)
(PMID:33223535)
2019
Pennel, K. A.F., Park, J. H. , McMillan, D. C. , Roseweir, A. K. and Edwards, J.
(2019)
Signal interaction between the tumour and inflammatory cells in patients with gastrointestinal cancer: implications for treatment.
Cellular Signalling, 54,
pp. 81-90.
(doi: 10.1016/j.cellsig.2018.11.013)
(PMID:30453014)
This list was generated on Thu Dec 7 22:34:53 2023 GMT.
